Intended for healthcare professionals
- News & Views
- Fluoroquinolone...
- Fluoroquinolone resistance in Salmonella Typhi
Letters
Fluoroquinolone resistance inSalmonella Typhi
BMJ2006;333 doi:https://doi.org/10.1136/bmj.333.7563.353-b(Published 10 August 2006) Cite this as:BMJ 2006;333:353
- Fiona J Cooke(fiona@sanger.ac.uk), MRC clinical research training fellow,
- John Wain, member of faculty,
- E John Threlfall, professor
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA
- Health Protection Agency, Centre for Infections, London NW9 5HT
EDITOR—As Parry et al point out,12 appropriate laboratory methods are crucial in detecting clinically important quinolone resistance.
We highlight the emergence of strains ofSalmonella enterica serovar Typhi (S Typhi) that show reduced susceptibility to the fluoroquinolones but are susceptible to nalidixic acid (minimum inhibitory concentration < 16 mg/l). In a review of all 692 isolates ofS Typhi sent to the Laboratory …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.
